News & Articles
Selected Filters:
Ascletis-Developed Ganovo Presented with Top Clinical Research Award
The Ganovo Phase III clinical study won the top award at the Infectious Disease National Congress of Chinese Medical Association by unanimous vote
Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project
Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance
New Method Reveals How Well Cancer Drugs Hit Their Targets
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
New Range of Flush Solutions Designed to Improve Analytical Instrument Performance
Thermo Scientific ChromaCare flush solutions and Thermo Scientific UHPLC-MS solvents intend to help prevent protein precipitation for high-quality chromatograms
Cancer Fighting Effects of Aspirin Revealed in Bowel Tumor Study
Experts find that the painkiller blocks a key process linked to tumor formation
New Accessories for Testing Nebulisers with Facemasks
Copley Scientific unveils new products to investigate the impact of facemasks when used in place of a mouthpiece
Free Webinar: Kinetic Characterization of Covalent Inhibitors on the PHERAstar
Learn how the use of covalent compounds within the pharmaceutical industry can improve drug discovery
SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)
Complete and easy-to-use LC-MS-based solution for biotherapeutics characterization and quality testing
New Protein Characterization Instrument System Transforms Biotherapeutic Analysis
RedShiftBio launches new AQS3pro System for protein characterization
Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test
Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs
Thermo Fisher Scientific Unveils Gibco ExpiSf System
The novel insect protein expression system promises superior protein yields, consistent results, a streamlined workflow and scales from discovery to production
A Collaboration of Giants for Cancer Research
AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics
Funding Gift Program Announced for Cancer Research Breakthroughs
The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics
BioAscent Establishes Integrated Drug Discovery Solutions
The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers
Results for CheckMate -277 Phase III Clinical Trial Presented at AACR 2018
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
New Trial Indicates Safe & Effective Neoadjuvant Treatment for Lung Cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
Developing a New Therapeutic for Tuberculosis
HER2 Mutations Linked to Tumor Survival Post Hormone Therapy
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer